Giuseppe De Rosa

Mr. Giuseppe De Rosa

Università Cattolica del Sacro Cuore - Fondazione Policlinico Universitario A. Gemelli IRCCS
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
Pier Carmine PassarelliPier Carmine Passarelli
Pier Carmine Passarelli
ANAndrea Netti
Andrea Netti
MLMichele Antonio ANTONIO Lopez
Michele Antonio ANTONIO Lopez
EGEleonora Favetti Giaquinto
Eleonora Favetti Giaquinto
GRGiuseppe De Rosa
Giuseppe De Rosa
ADAntonio D’addona
Antonio D’addona
Most studies indicate that the mechanical removal of the bacterial biofilm from the implant surface is the central goal of peri-implantitis therapy. However, controversial results in the treatment of peri-implantitis have led to the consideration of additional strategies that include surgical approaches and chemical adjuvants. Local/topical antibiotics, such as minocycline, azithromycin, tetracycline, amoxicillin, doxycycline, and metronidazole, may improve the efficacy of the definitive treatment of the disease, but the lack of conclusive findings prevents their use in clinical practice. This systematic review aimed to evaluate the effect of local/topical antibiotics for peri-implantitis treatment. Randomised controlled studies (RCT) on patients with peri-implantitis and comparing the efficacy of local/topical antibiotics vs. placebo or mechanical debridement were included. A systematic search strategy was carried out using three registered databases (PubMed, Web of Science, and Scopus). RoB2 was used to assess risk of bias. Five RCTs were identified (n = 250 patients and 333 implants). Contrast results emerged among the included studies, and a high heterogeneity level was observed. Risk of bias revealed some concerns for three studies out of five, while one study was judged at high risk. Only one study analysed the limitations of its findings. Overall, local antibiotic use can be considered a valid approach in the treatment of peri-implantitis. Therefore, future long-term clinical trials with standardised protocols and antibiotics with similar biological activity profiles should be tested to achieve a valid and definitive conclusion.

21 March 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Paolo De AngelisPaolo De Angelis
Paolo De Angelis
Giulio GaspariniGiulio Gasparini
Giulio Gasparini
Paolo Francesco ManiconePaolo Francesco Manicone
Paolo Francesco Manicone
Pier Carmine PassarelliPier Carmine Passarelli
Pier Carmine Passarelli
Domenico AzzolinoDomenico Azzolino
Domenico Azzolino
ADAntonio D'Addona
Antonio D'Addona
Diet and nutrition are generally categorized as modifiable lifestyle risk factors for the development of periodontal disease because diet may influence a person’s inflammatory status. This study aimed to evaluate the efficacy of the application of a diet plan focused on reducing inflammation and oxidative stress in treating periodontitis. Subjects suffering from periodontitis were divided into two groups. Both groups underwent non-surgical periodontal therapy, and in the optimized diet (OD) group, this treatment was associated with a diet plan. The sample consisted of 60 subjects; 32 (53%) were treated in the non-optimized diet group (ND group) and 28 (47%) in the OD group. In both groups, the periodontal treatment significantly improved the recorded periodontal outcomes between T0 and T1 (FMPS, FMBS, CAL, PPD). Inter-group differences were not statistically significant (p < 0.05). The linear regression models showed that the optimized diet was associated with a higher reduction in PPD and FMBS after the treatment, while patients who had higher LDL levels (over 100 mg/mL) had a less favorable improvement of PPD. The application of an improved diet plan can increase the reduction in PPD and FMBS after non-surgical periodontal therapy when compared with periodontal treatment alone.

19 June 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
Paolo De AngelisPaolo De Angelis
Paolo De Angelis
Edoardo RellaEdoardo Rella
Edoardo Rella
Paolo Francesco ManiconePaolo Francesco Manicone
Paolo Francesco Manicone
GRGiuseppe De Rosa
Giuseppe De Rosa
SGSofia Gallottini
Sofia Gallottini
ADAntonio D'Addona
Antonio D'Addona
Guided bone regeneration (GBR) is a reconstructive procedure for treating atrophic alveolar ridges. This study aims to assess the correlation between different glycemic control levels and clinical findings in patients undergoing horizontal GBR before implant placement. The study population consisted of all patients requiring horizontal GBR. Patients were divided into three groups based on HbA1c levels: non-diabetic normoglycemic patients (HbA1c < 5.7%), non-diabetic hyperglycaemic patients (HbA1c < 6.5%), and patients with controlled diabetes (HbA1c < 7%). The primary outcomes were the horizontal (mm) and vertical (mm) dimensional changes of the alveolar ridge 6 months after the procedure. The study sample consisted of 54 patients. Sixty-eight implants (95.8%) were classified as “successful,” meaning the possibility of inserting a standard-sized implant following the GBR (diameter ≥ 4 mm). There was a statistically significant difference between the three groups in terms of horizontal gain at 6 months: in particular, there was a statistically significant difference between group 1 and group 2 (p = 0.026) and between group 1 and group 3 (p = 0.030). The present investigation showed that patients with HbA1c levels below 7% could undergo GBR and obtain a statistically significant horizontal bone gain.

9 May 2024 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
Paolo De AngelisPaolo De Angelis
Paolo De Angelis
CCCamilla Cavalcanti
Camilla Cavalcanti
Paolo Francesco ManiconePaolo Francesco Manicone
Paolo Francesco Manicone
MLMargherita Giorgia Liguori
Margherita Giorgia Liguori
Edoardo RellaEdoardo Rella
Edoardo Rella
ADAntonio D'Addona
Antonio D'Addona
In cases of severe horizontal atrophy, implant placement requires bone reconstruction procedures. The aim of this randomized controlled trial is to compare the outcomes of bone augmentation with simultaneous implant placement using the shell technique to the outcomes of guided bone regeneration (GBR) in cases of severely horizontal bone atrophy. This study was designed as a monocentric, parallel-group, randomized controlled trial with a six-month follow-up. Among the primary outcomes of this study, peri-implant bone regeneration and peri-implant bone defect closure were selected. Forty-four patients were recruited and equally divided between two groups. In the GRB group, a horizontal regeneration of 2.31 ± 0.23 mm was observed opposed to a horizontal regeneration of 2.36 ± 0.17 mm in the shell group (p = 0.87). A volumetric increase was observed in both groups, with an increase of 0.30 ± 0.12 cm3 in the GBR group and an increase of 0.39 ± 0.09 cm3 in the shell group, highlighting a significant difference between the two groups (p = 0.02). In conclusion, bone augmentation with simultaneous implant placement using the shell technique or guided bone regeneration in horizontal bone atrophy are both predictable therapeutic options.

27 October 2023 in The Journal of Prosthetic Dentistry
Verified
Journal Article
Closed access
PAPaolo De Angelis
Paolo De Angelis
PMPaolo Francesco Manicone
Paolo Francesco Manicone
GRGiuseppe De Rosa
Giuseppe De Rosa
AGAlessandro De Giorgi
Alessandro De Giorgi
MLMargherita Giorgia Liguori
Margherita Giorgia Liguori
EREdoardo Rella
Edoardo Rella

16 August 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
Paolo De AngelisPaolo De Angelis
Paolo De Angelis
GRGiuseppe De Rosa
Giuseppe De Rosa
ICIacopo Cioccoloni
Iacopo Cioccoloni
ASAlberto Staffieri
Alberto Staffieri
Gioele GiocoGioele Gioco
Gioele Gioco
CLCarlo Lajolo
Carlo Lajolo
Background: Vertical implant positioning may influence peri-implant health outcomes and long-term stability; however, the impact of baseline vertical implant positioning relative to adjacent teeth remains unclear. The aim of this systematic review and meta-analysis was to assess the association between baseline vertical implant positioning and peri-implant clinical and radiographic outcomes. Methods: The Cochrane Central Register, PubMed, SCOPUS, and Web of Science were searched. Vertical implant positioning relative to adjacent teeth was assessed using two radiographic reference distances: implant platform to cemento-enamel junction (IP–CEJ) and implant platform to adjacent interproximal alveolar bone level (IP–ABL). The primary outcome was peri-implant marginal bone loss (MBL). Secondary outcomes included implant survival and success rates, peri-implant mucositis and peri-implantitis prevalence. Risk of bias was assessed using the Moga checklist, and certainty of evidence was evaluated according to GRADE. Results: Four studies including 267 implants fulfilled the inclusion criteria. The pooled mean baseline IP–CEJ and IP–ABL distances were 4.69 mm (95% CI 2.05 to 7.32) and 2.13 mm (95% CI 1.29 to 2.98), respectively. The pooled mean marginal bone loss after at least 12 months, based on three studies, was 0.21 mm (95% CI −0.28 to 0.70). Conclusions: The available evidence is insufficient to determine whether baseline IP–CEJ or IP–ABL distances are associated with peri-implant outcomes or to identify an optimal range of vertical implant positioning. The findings should be interpreted cautiously because the certainty of evidence is very low, highlighting the need for prospective studies with long-term follow-up.